What Is This About?

If you recently received a letter or an email from ADT Inc. informing you that your sensitive personal information was compromised in a data breach, we would like to speak with you about your rights and potential legal remedies. ADT Inc. recently disclosed that it was the victim of a data breach that exposed individuals’ sensitive personal information.

What Happened?

On or around April 20, 2026, ADT Inc. detected a cybersecurity incident in which its network servers were accessed without authorization. According to allegations in a proposed class action complaint, the intrusion resulted in the exfiltration of private information belonging to ADT customers and prospective customers. A cybercriminal group known as ShinyHunters claimed responsibility and publicly alleged it accessed over 10 million records containing personally identifiable information and internal corporate data. ADT’s public acknowledgment of the incident reportedly came via a statement posted on its website approximately four days after the incident occurred. The provided information does not state whether ADT retained third-party forensic investigators, the exact date ADT completed its data review/identified affected individuals, when (or if) individual notice letters were sent, or whether any state Attorney General or other government notifications were filed.

What Information Was Impacted?

Upon information and belief, the following types of sensitive personal information may have been compromised:

• "Names";
• "Phone numbers";
• "Addresses";
• "Dates of birth";
• "Partial Social Security numbers";
• "Tax identification numbers";
• "Personally identifiable information (PII)";
• "Internal corporate data (as publicly claimed by the threat actor)" .

What Action Can You Take?

Levi & Korsinsky, LLP is investigating whether affected users are entitled to compensation. If you received a notice from ADT Inc., there is no cost or obligation to participate. Follow the link below to find out about your rights and potential legal remedies available.